Venkata Ramalingayya Grandhi

Title: Venkata Ramalingayya Grandhi: Innovator in Pharmaceutical Applications

Introduction

Venkata Ramalingayya Grandhi is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cognitive disorders. His innovative work has led to the development of a patent that addresses various mental health issues.

Latest Patents

Venkata Ramalingayya Grandhi holds a patent for the "Uses of a 5-HT4 receptor agonist." This invention relates to new applications of Isopropyl-3-{5-[1-(3-methoxypropyl)piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole (Compound-1) or its pharmaceutically acceptable salts. The patent focuses on treating dementia due to menopause, senile dementia, cognitive deficits associated with schizophrenia, and other behavioral and psychological symptoms of dementia. The invention also provides methods for manufacturing medicaments intended for these disorders.

Career Highlights

Venkata Ramalingayya Grandhi is associated with Suven Life Sciences Limited, a company known for its research and development in the pharmaceutical sector. His work has been instrumental in advancing treatments for cognitive impairments and related conditions.

Collaborations

He has collaborated with notable colleagues such as Ramakrishna Nirogi and Abdul Rasheed Mohammed, contributing to the innovative research environment at Suven Life Sciences Limited.

Conclusion

Venkata Ramalingayya Grandhi's contributions to pharmaceutical innovations highlight the importance of research in addressing mental health challenges. His patent for the 5-HT4 receptor agonist exemplifies the potential for new treatments in cognitive disorders.